Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 18, 2023
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
Stephen Willey Maintained (XENE) at Strong Buy with Increased Target to $62 on, Dec 18th, 2023
Stephen Willey of Stifel, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Increased Target from $53 to $62 on, Dec 18th, 2023.
Stephen has made no other calls on XENE in the last 4 months.
There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Stephen's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Stephen
- Brian Skorney of "Baird" Initiated at Buy and Held Target at $63 on, Friday, December 8th, 2023
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $56 on, Tuesday, November 28th, 2023
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $46 on, Thursday, November 9th, 2023
- Josh Schimmer of "Cantor Fitzgerald" Initiated at Buy on, Tuesday, October 24th, 2023
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $58 on, Tuesday, August 22nd, 2023
